Direct comparison between in vivo and in vitro microsized particle phagocytosis assays in Drosophila melanogaster

K Adolfsson1, L Abariute1, A P Dabkowska2

  • 1Division of Solid State Physics, Box 118, 221 00 Lund, Sweden; NanoLund, Box 118, 221 00 Lund, Sweden.

Insights

Discrepancies between in vivo and in vitro immune cell assays for microparticles were investigated. In vitro assays showed lower particle uptake, possibly due to reduced cell membrane availability in cultured cells.

Area of Science:

  • Immunology
  • Cell Biology
  • Biomaterials Science

Background:

  • * In vivo and in vitro assays for micro and nanoparticles' effects on the innate immune system show discrepancies.
  • * Understanding these differences is crucial for accurate nanomaterial safety and efficacy assessment.

Purpose of the Study:

  • * To investigate the reasons for discrepancies between in vivo and in vitro phagocytosis assays.
  • * To compare phagocytosis of polystyrene microspheres by immune cells in Drosophila melanogaster in vivo versus in vitro.

Main Methods:

  • * Establishment of an in vivo phagocytosis assay using polystyrene microspheres in Drosophila melanogaster.
  • * Comparison with an in vitro phagocytosis assay using the same immune cells and particles.
  • * Analysis of the distribution of phagocytized beads per cell.

Main Results:

  • * The in vitro assay showed a shift towards lower numbers of phagocytized beads per cell compared to the in vivo assay.
  • * This difference suggests reduced membrane availability in cultured immune cells may impact phagocytosis.

Conclusions:

  • * In vitro phagocytosis assays may underestimate particle uptake compared to in vivo conditions.
  • * Reduced cell membrane availability in cultured cells is a potential factor contributing to assay discrepancies.
  • * Further research is needed to reconcile in vivo and in vitro findings for accurate nanomaterial assessment.

Related Concept Videos